.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Argus Health
Colorcon
Baxter
Julphar
Deloitte
Novartis
Citi
Fish and Richardson
Accenture

Generated: December 14, 2017

DrugPatentWatch Database Preview

Bisoprolol fumarate; hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for bisoprolol fumarate; hydrochlorothiazide and what is the scope of bisoprolol fumarate; hydrochlorothiazide patent protection?

Bisoprolol fumarate; hydrochlorothiazide
is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Apothecon, Ivax Sub Teva Pharms, Mylan, Sandoz, Teva, Unichem, Watson Labs Teva, and Teva Branded Pharm, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twelve drug master file entries for bisoprolol fumarate; hydrochlorothiazide. Fourteen suppliers are listed for this compound.

Summary for bisoprolol fumarate; hydrochlorothiazide

Pharmacology for bisoprolol fumarate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MylanBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075768-003Sep 25, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075527-002Sep 25, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075579-003Sep 25, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075527-001Sep 25, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075686-002Jan 19, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075672-003Sep 25, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ApotheconBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075642-002Dec 27, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075686-001Jan 19, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ivax Sub Teva PharmsBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL075632-002Sep 27, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
UnichemBISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDEbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL079106-001Jul 28, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: bisoprolol fumarate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded PharmZIACbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL020186-003Mar 26, 1993► Subscribe► Subscribe
Teva Branded PharmZIACbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL020186-002Mar 26, 1993► Subscribe► Subscribe
Teva Branded PharmZIACbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL020186-001Mar 26, 1993► Subscribe► Subscribe
Teva Branded PharmZIACbisoprolol fumarate; hydrochlorothiazideTABLET;ORAL020186-003Mar 26, 1993► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Colorcon
Medtronic
AstraZeneca
Boehringer Ingelheim
Fish and Richardson
Argus Health
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot